CHYM vs TMO · rev $543.5M vs P/E 24, rev $44.56B
Chime Financial, Inc. Class A Common Stock (CHYM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Chime Financial, Inc. Class A Common Stock (CHYM) is a software - application company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CHYM revenue for 2025-09-30 was $543.5M. Net income was -$54.7M. Revenue was up 2.9% from 2025-06-30 to 2025-09-30. CHYM currently screens at market cap $11.53B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CHYM currently screens at market cap $11.53B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CHYM and TMO stock pages for the full models.
Not investment advice.